Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

About this grant

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies for analyzing, targeting, probing, handling, or quality control of biospecimens used in cancer research or clinical care. The emphasis of this NOFO is on early-stage projects proposing proof-of-concept/pilot studies to test the feasibility of the proposed method, tool, assay, platform, or instrument. Well-suited applications must offer a Grant Number: RFA-CA-26-001. Expected awards: 17.

Eligibility requirements

All of the following criteria must be met:

• Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
• Grant Number: RFA-CA-26-001

What the funding covers

• Award Range: $50,000 to $1,50,000
• Expected Number of Awards: 17
• Total Program Funding: $47,00,000

How to apply

1. 1Applications must be submitted through grants.gov
2. 2Grant Number: RFA-CA-26-001
3. 3Posted: 2025-09-08

Application tips